Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock plunges 27%

by | Feb 9, 2026 | news, Top News

Spread the love
Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments